Advanced Search

Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2010 December;62(6) > Minerva Ginecologica 2010 December;62(6):533-9



A Journal on Obstetrics and Gynecology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index

Frequency: Bi-Monthly

ISSN 0026-4784

Online ISSN 1827-1650


Minerva Ginecologica 2010 December;62(6):533-9


Gestational diabetes and fetal growth acceleration: induction of labour versus expectant management

Alberico S. 1, Businelli C. 1, Wiesenfeld U. 1, Erenbourg A. 1,2, Maso G. 1, Piccoli M. 1, Ronfani L. 2

1 Unit of Obstetrical Pathology, Department of Obstetrics and Gynecology, IRCCS Burlo, Garofolo, Trieste, Italy;
2 Epidemiology and Biostatistics Unit, IRCCS Burlo Garofolo, Trieste, Italy

AIM: The aim of the study was to compare elective induction of labour at 38 weeks versus expectant management in A1 and A2 gestational diabetes (GDM) pregnancies with fetal growth acceleration. Primary outcome of the study was C-section (CS) rate, while secondary outcomes were macrosomia incidence and adverse perinatal outcomes.
METHODS: A retrospective cohort study was carried out. Data were collected between 1996 and 2006 and evaluated through patients’ records analysis. Differences between the two study groups were investigated using non-parametric tests for continuous variables and χ2 test for categorical ones.
RESULTS: There was no significant difference between induction and expectant management in terms of caesarean section rate. A trend favoring women in the induction group in terms of incidence of macrosomia and neonatal outcomes was identified, but results were not statistically significant.
CONCLUSION: Labour induction at 38 weeks in GDM patients with fetal growth acceleration does not seem to determine an increased incidence of C-section in comparison to expectant management, particularly in case of maternal obesity.

language: English


top of page